WEHI Ventures was established in 2023 to manage 66ten, the first internal pre-seed and seed fund created by Australian medical research institute, WEHI. 66ten is investing A$66M over 10 years to build on WEHI’s track record of commercial success. WEHI Ventures brings the brightest of seed stage R&D programs developed at or in collaboration with WEHI forward to co-investment partners globally. WEHI Ventures is overseen by an investment committee of experienced biotech entrepreneurs, Venture Capital investment managers and industry R&D leaders, and supports its ventures through an agile team of experienced early-stage drug discovery and development experts.
Find out more: www.wehi.edu.au/wehi-ventures
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1g Royal Parade, Parkville,victoria 3040,australia
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- HQ
- Parkville, Victoria
Wehi Ventures Questions
Wehi Ventures's website is http://www.wehi.edu.au/wehi-ventures
Wehi Ventures's LinkedIn profile is https://au.linkedin.com/company/wehi-ventures
Wehi Ventures has
6 employees.
View email and phone details for 6
employees at Wehi Ventures.
Wehi Ventures's industry is
Investment Management
Wehi Ventures's top competitors are
Tin Alley Ventures,
Jumar Bioincubator,
Uniseed,
Dogma Biotech,
Wehi (Walter And Eliza Hall Institute Of Medical Research),
Exogene,
Brandon Capital,
Proxima Bio,
Cell Bauhaus,
The Florey.
Wehi Ventures's categories are Investment Management
Wehi Ventures's founding year is 2023
